00Read later0Read MorePharmaTher targets new U.S. peptide pathway with 3D printed colon-release tablets3D Printing Industry·Paloma Duran·7 days ago#nlqBcqPE#3dprintingindustry#pharmather#holdings#building#range+4 more🧰Tag tools✨Add tagPharmaTher Holdings is building a range of 3D printed peptide products for a new U.S. compounding pathway. The first two are oral tablets of KPV and BPC-157 designed to release their dose in the colon. It is timed to the U.S.… Read more15s